These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38977110)
1. Elevated expression of ECT2 as a diagnostic marker and prognostic indicator in endometrial cancer. Wu XG; Wu Y; Pan YH; Chen JJ; Huang SY; Zhou XX; Zhong XQ; Ding ZA; Qiu YZ; Wang W; Fan LS Gene; 2024 Nov; 927():148756. PubMed ID: 38977110 [TBL] [Abstract][Full Text] [Related]
2. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma. Zhang Q; Wang Y; Xue F Genet Res (Camb); 2022; 2022():3217248. PubMed ID: 36186000 [TBL] [Abstract][Full Text] [Related]
3. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma. Liu NT; Perng CL; Chou YC; Ko PS; Lin YJ; Lin YC; Chang CC; Wang YC; Shang HS; Chao TK PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191 [TBL] [Abstract][Full Text] [Related]
4. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer. Yang Q; Yu B; Sun J Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and genes associated with endometrial cancer based on gene expression profiling by bioinformatics analysis. Zhang Y; Zhang W; Li X; Li D; Zhang X; Yin Y; Deng X; Sheng X Arch Gynecol Obstet; 2016 Jun; 293(6):1287-95. PubMed ID: 26437953 [TBL] [Abstract][Full Text] [Related]
6. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients. Jiang P; Sun W; Shen N; Huang X; Fu S BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095 [TBL] [Abstract][Full Text] [Related]
7. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis. Zhu Y; Shi L; Chen P; Zhang Y; Zhu T World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130 [TBL] [Abstract][Full Text] [Related]
8. Integrated Analysis of ECT2 and COL17A1 as Potential Biomarkers for Pancreatic Cancer. Huang WL; Wu SF; Huang X; Zhou S Dis Markers; 2022; 2022():9453549. PubMed ID: 35722628 [TBL] [Abstract][Full Text] [Related]
9. ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway. Xu D; Wang Y; Wu J; Zhang Z; Chen J; Xie M; Tang R; Chen C; Chen L; Lin S; Luo X; Zheng J Cell Death Dis; 2021 Feb; 12(2):162. PubMed ID: 33558466 [TBL] [Abstract][Full Text] [Related]
10. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
11. Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics. Xu X; Lu F; Fang C; Liu S J Healthc Eng; 2022; 2022():7832618. PubMed ID: 35242299 [TBL] [Abstract][Full Text] [Related]
12. Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma. Lan H; Yuan J; Chen X; Liu C; Guo X; Wang X; Song J; Cao K; Xiao S Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34859821 [TBL] [Abstract][Full Text] [Related]
13. TCGA dataset screening for genes implicated in endometrial cancer using RNA-seq profiling. Fu X; Cheng S; Wang W; Shi O; Gao F; Li Y; Wang Q Cancer Genet; 2021 Jun; 254-255():40-47. PubMed ID: 33588182 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis. Huang S; Pang L; Wei C Front Genet; 2021; 12():678780. PubMed ID: 34616422 [TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of ESPL1 is associated with poor prognostic outcomes in endometrial cancer. Yang Y; Sheng Y; Zheng J; Ma A; Chen S; Lin J; Yang X; Liang Y; Zhang Y; Zheng X Biomarkers; 2024 Jun; 29(4):185-193. PubMed ID: 38568742 [TBL] [Abstract][Full Text] [Related]
17. Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer. Shi YX; Yin JY; Shen Y; Zhang W; Zhou HH; Liu ZQ Sci Rep; 2017 Aug; 7(1):8072. PubMed ID: 28808310 [TBL] [Abstract][Full Text] [Related]
18. CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer. Wang Y; Zhao S; Qin Q; Gao X; Zhang X; Zhang M; Jiang Y; Ji X; Zhu H; Zhao X; Li H PLoS One; 2022; 17(1):e0262000. PubMed ID: 35077462 [TBL] [Abstract][Full Text] [Related]
19. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer. Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648 [TBL] [Abstract][Full Text] [Related]
20. ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas. Mah V; Elshimali Y; Chu A; Moatamed NA; Uzzell JP; Tsui J; Schettler S; Shakeri H; Wadehra M Sci Rep; 2021 Jun; 11(1):11949. PubMed ID: 34099751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]